Carruthers JDA, Carruthers JA. Facial Sculpting and Tissue Augmentation. Dermatol
 Surg.2005;31: 1604-1612

Carruthers JDA. Aesthetic Blepharoplasty. Dermatology Focus. Vol24.No2.: 2,  Summer
      2005;24(2):7.

Hirsch Ranella J. , Narurkar Vic,  Carruthers JDA.   Management of Hyaluronic Acid
Induced Tyndall Effects . Lasers Surg Med. 38(202-204) 2006.

Carruthers A, Carruthers JDA. Botulinum Toxin Type A. Periodic Synopsis. J Am Acad
Dermatol. 2005;53:284-90

Carruthers A, Carruthers JDA, NJ Lowe, A Menter, J Gibson. One year  randomized  two      
period study of  the safety and efficacy of the treatment of glabellar lines  with Botulinum-
A exotoxin. J Clinical Research .2004 .7:1-20.

Carruthers JDA,Klein AW, Carruthers A, Glogau RG, Canfield D. Safety and Efficacy of
      Restylane for Improvement of Mouth Corners. Dermatologic Surgery 2005; 31(3):276-80

Dover JS, Carruthers JA, Carruthers JDA, Alam M. Clinical Use of Restylane ™
Skin Therapy Letter. Vol10, No1,: 5-7,  Feb 2005
      http://www.skintherapyletter.com/2005/10.1/2.html

Carruthers JDA, Fagien S, Matarasso SL. , and the BOTOX Consensus Group.
Consensus recommendations on the use of Botulinum Toxin type A in facial aesthetics .
Ophthalmic Plastic and Reconstructive Surgery . 21(2):165, March 2005.

Carruthers JDA, Fagien S, Matarasso SL, and the BOTOX Consensus Group. 
Introduction to the Consensus Recommendations. Plastic and Reconstructive Surgery.2004 Nov; 114 (6 Suppl): i-iii.

Carruthers JA, MD, Jean DA Carruthers MD A Prospective, Double-Blind, Randomized,     
 Parallel Group, Dose-Ranging Study of Botulinum Toxin Type A in Men with Glabellar
Rhytides, Dermatol Surg.2005 Oct; 31(10);1297-303.